Aicone Medical Services

Aicone has expertise in different business lines, such as Advanced Analytics and Innovation Management.Our Offices are in Hamburg | Mumbai | Bangkok | Kuala Lumpur | Manila. Aicone Biochip is a multi-antigen, multi-domain, fully quantitative serology COVID-19 test. These results will provide critical insights on whether individuals have high titres of potentially neutralising antibodies against SARS-CoV-2 that may protect against reinfection or whether booster vaccinations are required. Until recently there was no COVID-19 antibody test available to provide a quantitative result. Aicone Biochip is a lab-based biochip test that utilises protein folding technology ensuring that viral antigens are correctly folded, preserving all conformational and linear antibody binding sites. Aicone Biochip provides a more accurate determination of sero-prevalence by targeting over 10 different domains of SARS-CoV-2 proteins. There is a wide variation in antibody titres across SARS-CoV-2 infected individuals2. There is a high degree of variation in patient-specific antibody responses to the different domains of SARS-CoV-2 proteins3.